9 results match your criteria: "Hospital Metropolitano Vivían Pellas[Affiliation]"
Mult Scler Relat Disord
August 2021
Hospital Metropolitano, Quito, Ecuador.
Rev Chilena Infectol
December 2019
Hospital Metropolitano Vivían Pellas, Managua, Nicaragua.
Background: Central America experiences a high burden of dengue reporting about 8% of all cases in the continent. This work reports the epidemiology of dengue in the sub region in a 10 years period.
Aim: To describe the epidemiology of dengue in Central America and the Dominican Republic.
J Rheumatol
April 2019
From the Department of Immunology and Rheumatology, and Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City; Department of Rheumatology, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico; Department of Rheumatology, Hospital Universitario Dr. José E. González, Monterrey, Mexico; Department of Internal Medicine, Hospital Metropolitano Vivian Pellas, Managua, Nicaragua; Department of Rheumatology, Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador; Department of Rheumatology, Instituto Mexicano del Seguro Social, Guadalajara, Mexico; Department of Rheumatology, Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico; Department of Internal Medicine, Hospital Universitario de la Samaritana, Bogotá, Colombia.
Objective: The aim of this study was to describe the prevalence of erectile dysfunction (ED), as well as associated demographic and clinical features, in men with systemic lupus erythematosus (SLE), by means of a systematic, standardized evaluation.
Methods: We performed a transversal study in 8 tertiary care centers in Latin America. We included male patients ≥ 16 years who fulfilled ≥ 4 American College of Rheumatology criteria for SLE and had regular sexual activity, and evaluated them with the International Index of Erectile Function-5 questionnaire.
Kidney Int
March 2018
Section of Tropical Medicine, Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA. Electronic address:
Mesoamerican nephropathy is a devastating disease of unknown etiology that affects mostly young agricultural workers in Central America. An understanding of the mechanism of injury and the early disease process is urgently needed and will aid in identification of the underlying cause and direct treatment and prevention efforts. We sought to describe the renal pathology in Mesoamerican nephropathy at its earliest clinical appearance in prospectively identified acute case patients in Nicaragua.
View Article and Find Full Text PDFAIDS
September 2017
aAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo bCenter for AIDS Research, Kumamoto University, Kumamoto, Japan cFaculty of Health Sciences, Simon Fraser University, Burnaby dBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada eDepartment of Paediatrics, University of Oxford, Oxford, UK fCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico gInfectious Diseases Clinic, Roosevelt Hospital, Guatemala City, Guatemala hNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam iHIV National Laboratory, Honduran Ministry of Health jHospital Escuela Universitario, Tegucigalpa, Honduras kGorgas Memorial Institute for Health Studies, Panama City, Panama lHospital Metropolitano Vivian Pellas, Managua, Nicaragua mMinistry of Health, Belmopan, Belize nUniversity of California San Francisco, San Francisco, California oCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, Maryland pRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA qMurdoch University, Perth, Australia rVanderbilt University, Nashville, Tennessee, USA sDepartment of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
Objective: Long-acting rilpivirine is a candidate for preexposure prophylaxis (PrEP) for prevention of HIV-1 infection. However, rilpivirine resistance mutations at reverse transcriptase codon 138 (E138X) occur naturally in a minority of HIV-1-infected persons; in particular those expressing human leukocyte antigen (HLA)-B18 where reverse transcriptase-E138X arises as an immune escape mutation. We investigate the global prevalence, B18-linkage and replicative cost of reverse transcriptase-E138X and its regional implications for rilpivirine PrEP.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
May 2017
5 Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Objective (1) Determine the incidence and risk factors for congenital hearing loss. (2) Perform cost analysis of screening programs. Study Design Proportionally distributed cross-sectional survey.
View Article and Find Full Text PDFStem Cell Res
January 2017
Department of Orthopedics, Division of Sports Medicine, University of Miami, Miller School of Medicine, Miami, Miami, FL, USA; Diabetes Research Institute and Cell Transplant Center, University of Miami, Miller School of Medicine, Miami, Miami, FL, USA. Electronic address:
We present a series of ten patients with non-reconstructable peripheral vascular disease (PVD), secondary to arteriosclerosis (AS) and/or diabetes mellitus (DM), treated with local injection of non-expanded autologous, adipose-derived stromal vascular fraction (SVF) cells for the purposes of enhancing neovascularization and chronic wound healing. Adipose tissue was surgically harvested and processed to yield the heterogeneous SVF cells for immediate point-of-care injection. The gastrocnemius muscles and ulcers or wounds where present were locally injected with the resulting SVF.
View Article and Find Full Text PDFPLoS One
May 2017
Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Background: Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR survey in Nicaragua since ART introduction in the country in 2003.
View Article and Find Full Text PDFAnn Maxillofac Surg
August 2016
Department of Surgery, Division of Plastic Surgery, Saint Louis University, Saint Louis, MO 63103, USA; Department of Surgery, National Autonomous University of Nicaragua, Nicaragua; Department of Surgery, Hospital Metropolitano Vivian Pellas, Managua, Nicaragua. E-mail: